RNU6-699P

Across TCGA pan-cancer cohorts, RNU6-699P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-699P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-699P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-699P expression acts as an unfavorable survival marker.

HNSC, ESCA, and KIRC are the cancer types where RNU6-699P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.169	0.686	<.001	99	view →
ESCA	OS	Tertile	II,III,IV	0.089	0.693	<.001	90	view →
KIRC	DFS	Tertile	IV	0.083	0.641	<.001	36	view →
UCEC	DFS	Tertile	All	0.116	0.647	.015	36	view →
STAD	DFS	Tertile	All	0.167	0.558	.004	27	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-699P–HNSC (DFS)

Open the HNSC breakdown →